euretinacongressdaily.org Open in urlscan Pro
2606:4700:3036::ac43:9c84  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content


EURETINA CONGRESS DAILY



Welcome to EURETINA Congress Daily

 * Latest news
 * EIS 2023
 * Day 1
 * Day 2
 * Day 3
 * Day 4
 * Photo Galleries


Euretina Congress Daily



Welcome to EURETINA Congress Daily

Main Menu
 * Latest news
 * EIS 2023
 * Day 1
 * Day 2
 * Day 3
 * Day 4
 * Photo Galleries


LATEST NEWS FROM EURETINA 2023



SPEAKERS’ CORNER PROVING BIG HIT WITH ATTENDEES

Delegates attending Saturday afternoon’s Speakers’ Corner session on imaging
heard colleagues describe interesting cases and findings from prospective and
retrospective clinical studies evaluating the performance of different imaging
platforms for characterising known and recently described retinal features
associated with common and rare diseases.   Speakers’ Corner, a popular feature
of...

Read More


EPOSTER WINNER: WHEN OIL STRIKES THE MACULA

A study detailing the pros and cons of using silicone oil as a long-term
tamponade agent after complex retinal surgery was the winner of the inaugural
August Deutman prize for the best e-Poster. “We know that silicone oil is a
widely used tamponade agent in complex retinal surgery, but it...

Read More


RETINAWS: WHEN THE GOING GETS TOUGH, THE TOUGH GET GOING

Delegates filling the Auditorium on Saturday morning for the RETINAWS video
course were rewarded with a valuable learning experience as top surgeons from
around the world presented and discussed video excerpts showcasing complex
vitreoretinal surgery, rare situations, and unique surgical techniques. The
session started, however, with course director Dr Kourous...

Read More


FREE PAPER WINNER: PULSAR TRIAL SHOWS EFFICACY OF AFLIBERCEPT 8 MG IN WET AMD

The PULSAR trial in wet age-related macular degeneration demonstrated that
aflibercept 8 mg administered every 12 or 16 weeks is noninferior in vision
gains compared with aflibercept 2 mg every 8 weeks. The 60-week and 96-week
outcomes of the trial were presented by Paolo Lanzetta MD, who was designated
winner...

Read More


SPECIALISTS DELVE DEEP TO UNRAVEL RETINAL MYSTERIES

Everybody loves a good detective mystery and retinal specialists are no
exception.  At the Medical Retina Mystery Cases session, the assembled audience
was presented with a wide variety of puzzling case studies which highlighted the
complex process of arriving at a correct diagnosis. Opening the session,
Srinivas Sadda MD presented...

Read More


EVER SYMPOSIUM: DEFUSING THE TICKING TIMEBOMB OF HIGH MYOPIA

If current trends continue, one out of every two people on the planet will be
myopic by the year 2050. Even more worryingly, a significant proportion of these
will be highly myopic with all the associated problems that entails in terms of
ocular morbidity, disease and vision loss, according to...

Read More


CHARTING EURETINA’S FUTURE: COLLABORATION, STANDARDS, AND CUTTING-EDGE RESEARCH

Prof. Ramin Tadayoni, the incoming President of EURETINA, discusses the
challenges and opportunities facing the Society over the next few years To what
do you attribute the phenomenal growth of EURETINA in recent years? Ramin
Tadayoni: EURETINA is still quite a young Society and a lot has been achieved
in...

Read More


AI, CLINICAL TRIALS & DIABETIC EYE DISEASE ALL ON THE MENU AT IMAGING SESSION

Speakers at the Euretina session on imaging reviewed applications for a variety
of retinal diseases. Leading off the programme, Dr Pearse Keane (UK) discussed
the application of artificial intelligence (AI) for analysing OCT scans and
predicted that the biggest impact of the application of AI in AMD in the near...

Read More


EURETINA REITERATES SUPPORT AT UKRAINE SYMPOSIUM

Presentations by Ukrainian retina specialists speaking at the Ukraine Support
Symposium on Friday afternoon described the devastating eye injuries suffered by
Ukrainian soldiers and civilians in the ongoing war with Russia and described
the complex surgical approaches needed to manage these traumatic cases.  
Opening the session, Dr Camiel Boon...

Read More


OPENING CEREMONY KICKS OFF 23RD EURETINA CONGRESS

There are 8,000 registered attendees for the 23rd Euretina Congress in
Amsterdam, also marking a return to the level of in-person attendance last seen
in 2019.  At the beginning of the opening ceremony on Thursday afternoon,
Euretina President Dr Alistair Laidlaw extended a very warm welcome to those who
gathered...

Read More


VITREORETINAL SURGERY: SEEKING THE GROUND TRUTH; EVIDENCE-BASED MEDICINE
APPROACHES IN RETINAL DETACHMENT AND MACULAR HOLES

A huge number of Euretina Congress delegates filled the Grand Auditorium to hear
speakers at the first Euretina Session of the meeting. The session focused on
vitreoretinal surgery and specifically centred on evidence-based medicine
approaches in cases of retinal detachment and macular holes.   The primary aim
of the session...

Read More


DEBATE CORNER: A SPACE FOR IDEAS AND OPEN CONVERSATION

‘Debate Corner’ was introduced as a new feature of the Euretina Congress at the
2023 meeting. Based on the large standing room only crowd in attendance at the
first of these sessions held in a corner of the Exhibit Hall, the format is a
huge success. The purpose of the...

Read More


136TH RETINAL DETACHMENT TEACHING COURSE: AN ENDURING INSTITUTION ROLLS ON

Mix of formats engage attendees and enhance learning in the 136th Retinal
Detachment Teaching Course EURETINA delegates who attended the Retinal
Detachment Teaching Course represent participants in the 136th iteration of this
programme that was first organised by Professor Ingrid Kreissig in 1991. The
course at the EURETINA Congress is...

Read More


INVESTMENT FIRM REPRESENTATIVES AT EIS PROVIDE POSITIVE OUTLOOK AND CONSTRUCTIVE
ADVICE FOR INNOVATORS

Retina specialists who have innovative ideas for new therapies and devices heard
encouraging words from panellists participating in the “Investing in Retina”
session at the EURETINA Innovation Spotlight. Representing European- and
US-based venture capital firms that provide financing for research and
development of entities that may be just a new...

Read More


EURETINA INNOVATION SPOTLIGHT (EIS) KICKS OFF WITH A FOCUS ON INTENSIVE
INNOVATION IN TREATMENT MODALITIES

Evidence of burgeoning research to develop new medical therapeutics for retinal
diseases was strong at the EURETINA Innovation Spotlight (EIS) where two
75-minute sessions were devoted to innovation in medical therapy. During the
dual sessions, speakers representing 13 companies took to the podium to showcase
their company’s pipeline, and panel...

Read More


INAUGURAL EURETINA INNOVATION SPOTLIGHT (EIS) LAUDED AS A HUGE SUCCESS

The Inaugural EURETINA Innovation Spotlight (EIS) held on October 4th, 2023
brought together the stakeholders involved in the development of the next
generation innovative retinal therapies and diagnostics. In launching this new
event, the goal of EURETINA was to create and foster communication and
collaboration to advance and improve the...

Read More


SIXTH ANNUAL EURETINA CLINICAL TRENDS SURVEY UNDERWAY: YOUR PARTICIPATION IS
ESSENTIAL!

Survey participants will be entered into a raffle to receive a free Delegate
registration for the EURETINA 2024 Congress in Barcelona and will receive a
summary report before it is published. The sixth annual EURETINA Clinical Trends
Survey is underway here in Amsterdam at the 2023 meeting. This survey builds...

Read More


GISBERT RICHARD LECTURE PREVIEW: OCT AT THE POINT OF CARE – A SURGEON’S
PERSPECTIVE

Gisbert Richard lecturer describes her 20+ year collaboration with engineering,
computer science, and clinical colleagues and their ongoing journey to improve
eye care through innovations in handheld and intraoperative OCT Without
exclusion, retina specialists recognise the value brought by optical coherence
tomography (OCT) to the care of patients with retinal...

Read More


FOCUS ON SUSTAINABILITY CONTINUES TO SHAPE CONGRESS PLANNING AND RECOMMENDATIONS

In his initial message inviting colleagues to the 23rd Euretina Congress in
Amsterdam, Euretina President Alistair Laidlaw said, “Sustainability will once
again be at the core of our conference organisation as we continue to measure
and lower our carbon output.” “Euretina is committed to improving the
sustainability of our Congress,...

Read More


AMSTERDAM SIGHTSEEING HIGHLIGHTS

With its picturesque canals, historic architecture, world-class museums, and
laid-back atmosphere, Amsterdam has no shortage of attractions to entice
delegates away from the conference centre. Here are five of the most captivating
highlights and best places to visit in this enchanting city. Van Gogh Museum:
One of Amsterdam’s most iconic...

Read More


KREISSIG LECTURE TO HIGHLIGHT POTENTIAL OF VR SURGERY FOR MANAGING UVEITIS

In the 2023 Kreissig Lecture, Professor Shwu-Jiuan Sheu MD, will outline the
potential advantages and pitfalls of employing vitreretinal surgery as a
management strategy for uveitis. In this interview, she discusses the key points
she will raise in her lecture. What is driving the development of VR surgery as
a...

Read More


EURETINA MENTORSHIP PROGRAMME 2023/2024

Strengthening the programme through participant feedback The Euretina Mentorship
programme is welcoming its third group of mentees as the Euretina Congress gets
underway in Amsterdam. Designed as a 1-year programme to run from Congress to
Congress, the programme aims to educate the wider ophthalmic community by
supporting the professional development...

Read More


YOURS COURSES PROVIDE OPPORTUNITY TO JUMPSTART PREPARATION FOR 2024 FEBOS-R EXAM

A group of 69 applicants seeking to become the first recipients of the FEBOS-R
completed the examination process on Wednesday 4th of October, the day before
the start of the Euretina Congress. While registration for next year’s exams
will not open until November, physicians interested in pursuing the FEBOS-R
diploma...

Read More


OPHTHALMOLOGICA LECTURE PREVIEW: BEYOND ATROPHY – INVESTIGATING THE LEADING
DISEASE FRONT

Ophthalmologica Award lecturer reviews the challenges faced in demonstrating the
efficacy of investigational treatments for atrophic retinal diseases and
possible solutions Geographic atrophy (GA) secondary to age-related macular
degeneration (AMD), and Stargardt disease (STGD) are leading causes of blindness
in the elderly and working-age populations, respectively. While no therapy
for...

Read More


EURETINA LECTURE PREVIEW: ONCOVR – A NEW SUBSPECIALTY?

EURETINA Lecture to highlight the unique knowledge and skills carried by oncoVR
surgeons and their contributions for improving the care of patients with
intraocular tumours Vitreoretinal surgery has an essential role in the diagnosis
and management of intraocular tumours. In his EURETINA Lecture entitled “OncoVR
– A new subspecialty”, Dr...

Read More




SOCIAL WALL



FOR FURTHER INFORMATION VISIT:




EURETINA.ORG



Copyright © 2023 Euretina Congress Daily